A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This was a randomized, placebo-controlled, investigator- and participant-blinded study to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of HSY244 in participants with atrial fibrillation (AF), with and without heart failure (HF).
Epistemonikos ID: a363241cf2f248c7314ea43db68ecf0433fcbfda
First added on: May 07, 2024